AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab Dr. Divya Colin13 April 2025 5:30 PM ISTNew Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Study reveals long-term asthma control with tezepelumab beyond treatment cessation Medha Baranwal7 May 2024 10:00 PM ISTUK: In a significant stride forward in asthma treatment research, the extended follow-up from the 2-year DESTINATION study sheds light on the dynamics...
Tezepelumab novel therapeutic approach in uncontrolled severe non-type 2 asthma, case study suggests Medha Baranwal12 March 2024 3:00 AM ISTJapan: A recent case study published in Respirology Case Reports has shown that Tezepelumab could serve as a novel therapy for patients with...
Tezepelumab Effectively Reduces Asthma Exacerbations in Patients Across BMI Ranges Dr Riya Dave16 Oct 2023 10:15 AM ISTA post hoc analysis was conducted on the phase 3 NAVIGATOR study and the DESTINATION extension study. The analysis revealed that tezepelumab, a human...
Tezepelumab Shows Promise in Reducing Mucus Plugs in Patients with Uncontrolled Asthma Dr Riya Dave3 Oct 2023 10:00 AM ISTAsthma, a chronic respiratory condition, often involves airway obstruction caused by mucus plugs and inflammation. A recent analysis of the CASCADE...
AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
Asthma treatment: AstraZeneca Tezspire approved for self-administration in EU in new pre-filled pen Ruchika Sharma15 Jan 2023 9:00 AM ISTTezspire will be available as a fixed-dose 210mg subcutaneous injection via a pre-filled, single-use auto-injector (the Tezspire pre-filled pen), in...
Tezepelumab plus allergy shots significantly lower symptoms in allergic rhinitis caused by cat allergens Dr. Kamal Kant Kohli10 Nov 2022 9:30 AM ISTResearchers have found in a new study that a combination of Tezepelumab and allergen Immunotherapy significantly lowers symptoms in allergic...
AstraZeneca severe asthma treatment Tezspire gets Japanese nod Ruchika Sharma28 Sept 2022 3:37 PM ISTUK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or...
AstraZeneca Severe Asthma treatment Tezspire gets nod in EU Ruchika Sharma22 Sept 2022 2:00 PM ISTTezspire (tezepelumab) is being developed by AstraZeneca in collaboration with Amgen.
USFDA grants Orphan Drug Designation to AstraZeneca Tezepelumab Ruchika Sharma11 Oct 2021 1:04 PM ISTUK: AstraZeneca has announced that Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for...
Tezepelumab reduces exacerbations by 86 percent in severe asthma patients: Study Hina Zahid7 Sept 2021 11:49 PM ISTUSA: Tezepelumab reduced exacerbations and improved lung function and nasal symptoms in patients with severe, uncontrolled asthma and comorbid nasal...
